KDM5B and non-small cell lung carcinoma: PBIT is a potent and specific inhibitor of JARID1B [25] (Fig. 5a), and we herein investigated the role of PBIT in NSCLC and evaluated its ability to suppress the potential and/or CSC phenotype of NSCLC cells.